Anna Faris

Anna Faris

Auto-generated profile, based on publicly available information

Anna Faris

Department of Urology, University of Michigan, Ann Arbor, Michigan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Journal of Urology
Verified
Journal Article
Closed access
JPJavier Pizarro-Berdichevsky
Javier Pizarro-Berdichevsky
BGBradley C. Gill
Bradley C. Gill
MCMarisa Clifton
Marisa Clifton
HOHenry T. Okafor
Henry T. Okafor
AFAnna E. Faris
Anna E. Faris
HGHoward B. Goldman
Howard B. Goldman
We sought to determine the usefulness of motor responses during sacral neuromodulation lead placement by testing the hypothesis that a greater number of motor responses during intraoperative electrode testing would be associated with more durable therapy. We retrospectively reviewed all sacral neuromodulation lead placements at a large academic center from 2010 to 2015. Included in study were all unilateral sacral lead placements for which the presence or absence of a motor response was documented discretely for each electrode. Motor responses were quantified into separate subscores, including bellows and toe response subscores (each range 0 to 4) for a possible maximum total score of 8 when combined. Revision surgery was the primary outcome. Univariate and multivariate analyses were performed for factors associated with lead revision. A total of 176 lead placements qualified for analysis. Mean ± SD cohort age was 58.4 ± 15.9 years, 86.4% of the patients were female and 93.2% had undergone implantation for overactive bladder. Median followup was 10.5 months (range 2 to 36). Overall 34 patients (19%) required lead revision. Revision was negatively associated with the total electrode response score (p = 0.027) and the toe subscore (p = 0.033) but not with the bellows subscore (p = 0.183). Predictors of revision on logistic regression included age less than 59 years at implantation (OR 5.5, 95% CI 2-14) and a total electrode response score less than 4 (OR 4.2, 95% CI 1.4-12.8). Fewer total electrode responses and specifically fewer toe responses were associated with sacral neuromodulation lead revision. These data suggest that placing a lead with more toe responses during testing may result in more durable sacral neuromodulation therapy.

1 August 2021 in Journal of Urology
Verified
Journal Article
Closed access
DFDonald Fedrigon
Donald Fedrigon
AFAnna Faris
Anna Faris
NKNaveen Kachroo
Naveen Kachroo
RJRajat Jain
Rajat Jain
MEMarlie Elia
Marlie Elia
SSSri Sivalingam
Sri Sivalingam
Purpose:Pain is the leading cause for unplanned emergency department visits and readmissions after ureteroscopy (URS), making post-operative analgesic stewardship a priority given the current opioi...

18 May 2022 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
AFAnna Faris
Anna Faris
LHLindsey Herrel
Lindsey Herrel
JMJames E. Montie
James E. Montie
SCStephanie Chisolm
Stephanie Chisolm
ADAshley Duby
Ashley Duby
DWDaniela Wittmann
Daniela Wittmann

1 May 2023 in Neurourology and Urodynamics
Verified
Journal Article
Closed access
AFAnna Faris
Anna Faris
GLGiulia I. Lane
Giulia I. Lane
RMRohit Mehra
Rohit Mehra
VDVipulkumar Dadhania
Vipulkumar Dadhania
ICIryna Crescenze
Iryna Crescenze
ACAnne P. Cameron
Anne P. Cameron

1 September 2025 in Urology Practice
Verified
Journal Article
Closed access
MCMarvin N. Carlisle
Marvin N. Carlisle
KLKevin D. Li
Kevin D. Li
SJStephanie L. Jarosek
Stephanie L. Jarosek
AFAnna R. Faris
Anna R. Faris
HPHiren V. Patel
Hiren V. Patel
BBBenjamin N. Breyer
Benjamin N. Breyer
Long-term urinary adverse events (UAEs) following prostate cancer treatment significantly impact survivor quality of life. Previous research suggests disparities in prostate cancer outcomes across geographic and sociodemographic lines, but a comprehensive analysis of treatment-related UAEs is lacking. Using SEER-Medicare data (1999-2019), we conducted a retrospective cohort study of men aged ≥66 with non-metastatic prostate cancer treated within 12 months of diagnosis. Rural versus urban residence was determined using Rural-Urban Continuum Codes. UAE risk was assessed using multivariable Cox models and competing risks regression, adjusting for demographics, education, income, comorbidities, and treatment type. Among 166,581 patients, rural residents (16% of cohort) showed lower 15-year cumulative UAE incidence compared to urban residents (17% versus 20%; p<0.001), despite having lower median per capita income ($18,595 vs. $26,343; p<0.001) and less education (19% vs. 12% without high school education; p<0.001). Rural residence was associated with lower UAE rates (adjusted HR [aHR] 0.90, 95% confidence interval [CI] 0.86-0.94). Higher risk was observed among Hispanic (aHR 1.18, 95% CI 1.11-1.25) and Non-Hispanic Black patients (aHR 1.11, 95% CI 1.05-1.16), those with lower education (aHR 1.31, 95% CI 1.23-1.39 for lowest vs. highest quartile), and patients aged ≥80 years (aHR 1.54, 95% CI 1.47-1.61). Rural residence was unexpectedly associated with lower UAE rates following prostate cancer treatment. However, significant disparities persisted across racial and socioeconomic lines, with higher risks among minority and less educated patients, suggesting complex relationships between geography, demographics, and treatment outcomes.

2 November 2022 in Urology Case Reports
Verified
Journal Article
Open access
AFAnna Faris
Anna Faris
JMJeffrey Montgomery
Jeffrey Montgomery
MHMiriam Hadj-Moussa
Miriam Hadj-Moussa
Rarely pelvic hemorrhage events can lead to bladder perforation. We present a 48-year-old female who devel-oped a spontaneous rectal sheath hematoma which perforated her bladder. Her case was monitored with serial MRI imaging and managed with two endoscopic clot resections which demonstrated new epithelialization of the bladder wall across the hematoma point of entry. We conclude that the bladder has an impressive potential to heal and select cases of symptomatic invasive bladder hematomas may be monitored with serial imaging and managed endoscopically.